ENDRA Life Sciences (NDRA) Share-based Compensation Growth (5y) (2021 - 2026)
Powered by 
Analysis
ENDRA Life Sciences (NDRA) Share-based Compensation Growth (5y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - |
| 10 | ENDRA Life Sciences | 8.25 Mn | 2.71 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 56.47% |
| Dec 31, 2025 | -67.31% |
| Sep 30, 2025 | -26.91% |
| Jun 30, 2025 | -40.85% |
| Mar 31, 2025 | -30.47% |
| Dec 31, 2024 | -22.70% |
| Sep 30, 2024 | -76.14% |
| Jun 30, 2024 | 13.73% |
| Mar 31, 2024 | 0.99% |
| Dec 31, 2023 | -4.03% |
| Sep 30, 2023 | 15.01% |
| Jun 30, 2023 | 11.80% |
| Mar 31, 2023 | 11.24% |
| Dec 31, 2022 | -6.29% |
| Sep 30, 2022 | 93.60% |
| Jun 30, 2022 | 95.99% |
| Mar 31, 2022 | 205.98% |
| Dec 31, 2021 | 68.18% |
| Sep 30, 2021 | 99.67% |
| Mar 31, 2021 | 32.70% |